Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
RESEARCH TOOLSreports
Cartesian Therapeutics (RNAC) Ownership - Who Owns Cartesian Therapeutics?
1,034 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 28, 2024 | Timothy A Springer Director, >10% Owner | Bought | $11388 |
| Mar 26, 2024 | Timothy A Springer Director, >10% Owner | Bought | $2876847 |
| Mar 20, 2024 | Timothy A Springer Director, >10% Owner | Bought | $11236 |
| Mar 18, 2024 | Timothy A Springer Director, >10% Owner | Bought | $661871 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $10878 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,001,254 | Institution | 108.80% | 112,643,538 | |
| 5,495,107 | Institution | 99.62% | 103,143,158 | |
| 5,385,728 | Institution | 97.64% | 101,090,115 | |
| 1,270,660 | Institution | 23.04% | 23,850,288 | |
| 1,080,767 | Institution | 19.59% | 20,285,997 | |
| 660,852 | Institution | 11.98% | 12,404,192 | |
| 528,838 | Institution | 9.59% | 9,926,289 | |
| 490,320 | Institution | 8.89% | 9,203,306 | |
| 463,092 | Institution | 8.40% | 8,692,237 | |
| 435,000 | Institution | 7.89% | 8,164,950 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,495,107 | Institution | 99.62% | 103,143,158 | |
| 5,385,728 | Institution | 97.64% | 101,090,115 | |
| 1,270,660 | Institution | 23.04% | 23,850,288 | |
| 1,080,767 | Institution | 19.59% | 20,285,997 | |
| 528,838 | Institution | 9.59% | 9,926,289 | |
| 490,320 | Institution | 8.89% | 9,203,306 | |
| 463,092 | Institution | 8.40% | 8,692,237 | |
| 435,000 | Institution | 7.89% | 8,164,950 | |
| 325,308 | Institution | 5.90% | 6,106,031 | |
| 94,737 | Institution | 1.72% | 1,778,213 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,799,067 | Institution | 68.88% | 2,469,394 | |
| 86,040 | Institution | 1.56% | 1,633,900 | |
| 1,696,040 | Institution | 30.75% | 1,102,426 | |
| 26,536 | Institution | 0.48% | 503,919 | |
| 407,871 | Institution | 7.39% | 265,116 | |
| 8,515 | Institution | 0.15% | 161,700 | |
| 8,342 | Institution | 0.15% | 158,415 | |
| 6,342 | Institution | 0.11% | 120,435 | |
| 3,157 | Institution | 0.06% | 61,214 | |
| 64,264 | Institution | 1.17% | 41,772 |
FAQ
Who Owns Cartesian Therapeutics (RNAC)?
Currently, no data Available
What percentage of Cartesian Therapeutics (RNAC) stock is held by institutional investors?
Currently, no data Available
What percentage of Cartesian Therapeutics (RNAC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cartesian Therapeutics (RNAC)?
Vanguard owns the most shares of Cartesian Therapeutics (RNAC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.